NutriSystem (NASDAQ:NTRI) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued to investors on Thursday.

According to Zacks, “Nutrisystem, Inc. is a leader in the weight loss industry, having helped millions of people loses weight. From the flagship Nutrisystem brand comes the clinically-tested Nutrisystem Lean13 program, designed to deliver weight loss of up to 13 pounds and seven inches in the first month. South Beach Diet became an all-new structured meal delivery weight-loss program following the acquisition of the brand. Additional Nutrisystem branded weight-loss products include Fast 5 and Turbo 10, as well as multi-day kits and individual products at select retail outlets. “

Several other research firms have also weighed in on NTRI. ValuEngine raised shares of NutriSystem from a “strong sell” rating to a “sell” rating in a report on Friday, August 3rd. Barrington Research reaffirmed a “hold” rating on shares of NutriSystem in a report on Wednesday, August 1st. BidaskClub lowered shares of NutriSystem from a “hold” rating to a “sell” rating in a report on Saturday, August 18th. DA Davidson lowered shares of NutriSystem from a “buy” rating to a “neutral” rating and dropped their price objective for the stock from $45.00 to $40.00 in a report on Tuesday, July 31st. They noted that the move was a valuation call. Finally, B. Riley raised their price objective on shares of NutriSystem from $52.00 to $53.00 and gave the stock a “buy” rating in a report on Tuesday, July 31st. Three research analysts have rated the stock with a sell rating, three have assigned a hold rating and four have issued a buy rating to the company. The stock has an average rating of “Hold” and an average target price of $44.50.

NASDAQ NTRI opened at $33.39 on Thursday. The company has a market cap of $967.53 million, a PE ratio of 17.04, a PEG ratio of 1.59 and a beta of 1.27. NutriSystem has a 1-year low of $26.06 and a 1-year high of $59.90.

NutriSystem (NASDAQ:NTRI) last posted its quarterly earnings data on Monday, July 30th. The company reported $0.87 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.81 by $0.06. The company had revenue of $191.30 million during the quarter, compared to analyst estimates of $189.07 million. NutriSystem had a net margin of 7.94% and a return on equity of 43.29%. The company’s revenue was down 1.8% on a year-over-year basis. During the same quarter last year, the business posted $0.80 earnings per share. Equities research analysts forecast that NutriSystem will post 2.06 EPS for the current year.

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. US Bancorp DE grew its stake in shares of NutriSystem by 64.7% during the second quarter. US Bancorp DE now owns 3,726 shares of the company’s stock valued at $143,000 after purchasing an additional 1,464 shares during the last quarter. Principal Financial Group Inc. grew its stake in shares of NutriSystem by 0.8% during the first quarter. Principal Financial Group Inc. now owns 250,443 shares of the company’s stock valued at $6,749,000 after purchasing an additional 2,095 shares during the last quarter. Legal & General Group Plc grew its stake in shares of NutriSystem by 3.9% during the second quarter. Legal & General Group Plc now owns 63,544 shares of the company’s stock valued at $2,434,000 after purchasing an additional 2,378 shares during the last quarter. Lapides Asset Management LLC grew its stake in shares of NutriSystem by 2.2% during the second quarter. Lapides Asset Management LLC now owns 120,500 shares of the company’s stock valued at $4,639,000 after purchasing an additional 2,600 shares during the last quarter. Finally, First Mercantile Trust Co. bought a new stake in shares of NutriSystem during the second quarter valued at approximately $119,000.

NutriSystem Company Profile

Nutrisystem, Inc, together with its subsidiaries, provides weight management products and services for women and men in the United States. The company offers weight loss programs that consist primarily of a pre-packaged food program, digital tools, and counseling. It also provides Nutrisystem Lean13 program, which provides weight loss, and support and counseling services; the South Beach Diet, a weight-loss program; and Nutrisystem 5-day kit, a ?D' kit that offers individuals with or at risk of type 2 diabetes.

Featured Article: How Buying a Call Option Works

Get a free copy of the Zacks research report on NutriSystem (NTRI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for NutriSystem (NASDAQ:NTRI)

Receive News & Ratings for NutriSystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NutriSystem and related companies with MarketBeat.com's FREE daily email newsletter.